```json
{
"content": [
{
"type": "paragraph",
"content": "The Premature Rupture of Membranes (PROM) Testing market focuses on diagnostic tools and procedures to identify the early rupture of amniotic membranes during pregnancy, a critical condition requiring timely intervention to prevent maternal and fetal complications. This market is gaining prominence due to rising preterm birth rates and advancements in obstetric care. The global PROM Testing market size is projected to reflect steady industry expansion, driven by technological innovation and growing awareness of maternal health. Key trends in the market forecast include the adoption of non-invasive diagnostics and regional regulatory shifts favoring rapid diagnostic solutions."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Invasive Tests", "Non-Invasive Tests", "Point-of-Care Diagnostics"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026"],
"values": [
[25, 26, 27, 28, 29, 30], // Invasive Tests
[15, 17, 19, 21, 23, 25], // Non-Invasive Tests
[10, 12, 14, 16, 18, 20] // Point-of-Care Diagnostics
]
}
},
{
"type": "paragraph",
"content": "The Premature Rupture of Membranes Testing market is anticipated to grow at a CAGR of 5.8% from 2026 to 2033, reaching an estimated USD 240 million by 2033. Primary growth drivers include the global rise in maternal health expenditures, increasing prevalence of high-risk pregnancies, and the integration of AI-driven diagnostic platforms. Regulatory harmonization across the EU and Asia-Pacific is accelerating market adoption, while competitive intensity is concentrated in the development of cost-effective, user-friendly testing kits. North America remains the largest regional market, while Southeast Asia and Africa are emerging as high-growth hubs due to expanding healthcare infrastructure and government-funded maternal care programs."
}
]
}
```
